Exendin (9-39)
Showing 26 - 50 of >10,000
Non-Valvular Atrial Fibrillation Trial in Worldwide (Omega™LAA Occluder implantation)
Recruiting
- Non-Valvular Atrial Fibrillation
- Omega™LAA Occluder implantation
-
København, Blegdamsvej 9, Denmark
- +7 more
Mar 10, 2022
Facial Angiofibroma, Tuberous Sclerosis Trial in Worldwide (rapamycin, )
Completed
- Facial Angiofibroma
- Tuberous Sclerosis
- rapamycin
- placebo
-
Phoenix, Arizona
- +16 more
Jul 26, 2022
Choroideremia, X-Linked Retinitis Pigmentosa Trial in Worldwide (BIIB111, BIIB112)
Enrolling by invitation
- Choroideremia
- X-Linked Retinitis Pigmentosa
- BIIB111
- BIIB112
-
Los Angeles, California
- +22 more
Apr 20, 2022
Cancer Trial in Indianapolis, Pittsburgh, Memphis (MAAT-YS)
Not yet recruiting
- Cancer
- MAAT-YS
-
Indianapolis, Indiana
- +2 more
Nov 27, 2023
Healthy Trial in Durham (Active Comparator: Sitagliptin, Placebo Comparator - No Sitagliptin)
Completed
- Healthy
- Active Comparator: Sitagliptin
- Placebo Comparator - No Sitagliptin
-
Durham, North CarolinaLeslie Willis
Apr 6, 2021
Idiopathic Parkinson Disease, Parkinson's Disease and Parkinsonism Trial in León (Adipose-derived stromal vascular fraction
Completed
- Idiopathic Parkinson Disease
- Parkinson's Disease and Parkinsonism
- Adipose-derived stromal vascular fraction cells
-
León, Leon, NicaraguaHospital Escuela Oscar Danilo Rosales Arguello
Jan 24, 2023
Insulinoma Trial in Fuzhou (68Ga-NOTA-exendin-4)
Recruiting
- Insulinoma
-
Fuzhou, Fujian, ChinaDepartment of Nuclear Medicine, First Affiliated Hospital of Fuj
Jul 29, 2022
Refractory or Recurrent Solid Tumors, Rhabdomyosarcoma, Non-Rhabdomyosarcoma Soft Tissue Sarcoma Trial in Worldwide (Eribulin
Completed
- Refractory or Recurrent Solid Tumors
- +3 more
- Eribulin mesilate
- Irinotecan hydrochloride
-
Marseille, Bouches-du-Rhône, France
- +38 more
Jun 20, 2022
Metastatic Hormone Sensitive Prostate Cancer Treated With
Not yet recruiting
- Metastatic Hormone-sensitive Prostate Cancer
-
Innsbruck, Austria
- +42 more
Jun 5, 2023
Schizophrenia Trial in Worldwide (SEP-363856 50mg, SEP-363856 75mg, Placebo)
Recruiting
- Schizophrenia
- SEP-363856 50mg
- +2 more
-
Little Rock, Arkansas
- +58 more
Dec 12, 2022
Glucose Metabolism Disorders Trial in Gentofte (Placebo Oral Tablet, Metformin, Saline)
Completed
- Glucose Metabolism Disorders
- Placebo Oral Tablet
- +3 more
-
Gentofte, Copenhagen, DenmarkCenter for Diabetes Research
Jul 6, 2018
Atopic Dermatitis Eczema Trial in Canada, United States (ARQ-151 Active, ARQ-151 Vehicle)
Active, not recruiting
- Atopic Dermatitis Eczema
- ARQ-151 Active
- ARQ-151 Vehicle
-
Montgomery, Alabama
- +48 more
Aug 10, 2022
Respiratory Syncytial Virus Trial in Worldwide (Ad26.RSV.preF, Placebo, Nimenrix)
Completed
- Respiratory Syncytial Virus
- Ad26.RSV.preF
- +2 more
-
Geelong, Australia
- +24 more
Nov 23, 2021
Primary Membranous Nephropathy Trial (SNP-ACTH (1-39) Gel, Rituximab)
Not yet recruiting
- Primary Membranous Nephropathy
- SNP-ACTH (1-39) Gel
- Rituximab
- (no location specified)
Jan 13, 2023
Parkinson Disease Trial in Korea, Republic of (Safinamide Mesilate)
Recruiting
- Parkinson Disease
- Safinamide Mesilate
-
Busan, Korea, Republic of
- +19 more
Apr 25, 2022
Diabetes Trial in Vienna, Paris (68Ga-NODAGA-exendin-4 PET/CT)
Recruiting
- Diabetes Mellitus
- 68Ga-NODAGA-exendin-4 PET/CT
-
Vienna, Austria
- +1 more
Jun 16, 2022
Post-traumatic Stress Disorder, Cocaine Use Disorder Trial in Zürich (Imagery, Minocycline, Placebo)
Recruiting
- Post-traumatic Stress Disorder
- Cocaine Use Disorder
- Imagery
- +2 more
-
Zürich, SwitzerlandPsychiatric University Hospital Zurich, University of Zurich
Jun 5, 2023
Plaque Psoriasis Trial in Canada, United States (Roflumilast Cream 0.3%, Roflumilast Cream 0.15%, Vehicle Cream)
Completed
- Plaque Psoriasis
- Roflumilast Cream 0.3%
- +2 more
-
Beverly Hills, California
- +29 more
Aug 31, 2022
Obesity Trial in Nashville (Sitagliptin, Pegvisomant, Placebo)
Completed
- Obesity
- Sitagliptin
- +4 more
-
Nashville, TennesseeVanderbilt University Medical Center
May 25, 2018
Labour at Thirty Nine Weeks: a Prospective Observational Study
Completed
- Pregnancy Related
- Elective Induction
-
Thrissur, Kerala, IndiaJubilee Mission Medical College and Research Institute
Mar 13, 2022
Cervical Cancer Trial in Chongqing, Fuzhou (TQB2868 injection, Paclitaxel injection, Cisplatin injection)
Not yet recruiting
- Cervical Cancer
- TQB2868 injection
- +4 more
-
Chongqing, Chongqing, China
- +1 more
Aug 17, 2023